Lactobacillus casei prevents the development of dextran sulphate sodium-induced colitis in Toll-like receptor 4 mutant mice

Clinical and Experimental Immunology

Volumn 151, Issue 1, 2008, Pages 182-189

  Chung, Y W ^a   Choi, J H ^b   Oh, T Y ^b   Eun, C S ^b   Han, D S ^b  

^a Hallym University   (South Korea)

^b Hanyang University Guri Hospital   (South Korea)

Author keywords

Dextran sulphate sodium induced colitis; Lactobacillus casei; Probiotics; Toll like receptor 4

Indexed keywords

DEXTRAN DERIVATIVE; DEXTRAN SULPHATE SODIUM; INTERLEUKIN 10; MESSENGER RNA; MYELOPEROXIDASE; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CELL INFILTRATION; COLITIS; CONTROLLED STUDY; FEMALE; HISTOLOGY; LACTOBACILLUS CASEI; MUTANT; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

ANIMALS; BIOLOGICAL MARKERS; COLITIS; COLON; DEXTRAN SULFATE; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERLEUKIN-10; INTERLEUKIN-12 SUBUNIT P40; INTESTINAL MUCOSA; LACTOBACILLUS CASEI; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MODELS, ANIMAL; PEROXIDASE; PROBIOTICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOLL-LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA;

EID: 36849007522     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2007.03549.x     Document Type: Article

References (29)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002 347 : 417 29.
2. Fort MM, Mozaffarian A, Stover AG et al. A synthetic TLR-4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease. J Immunol 2005 174 : 6416 23.
3. Shanahan F. Probiotics in inflammatory bowel disease. Gut 2001 48 : 609.
4. Gionchetti P, Rizzello F, Helwig U et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003 124 : 1202 9.
5. Cui HH, Chen CL, Wang JD et al. Effects of probiotic on intestinal mucosa of patients with ulcerative colitis. World J Gastroenterol 2004 10 : 1521 5.
6. Borruel N, Carol M, Casellas F et al. Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria. Gut 2002 51 : 659 64.
7. Borruel N, Casellas F, Antolin M et al. Effects of nonpathogenic bacteria on cytokine secretion by human intestinal mucosa. Am J Gastroenterol 2003 98 : 865 70.
8. Tien MT, Girardin SE, Regnault B et al. Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J Immunol 2006 176 : 1228 37.
9. Drakes M, Blanchard T, Czinn S. Bacterial probiotic modulation of dendritic cells. Infect Immun 2004 72 : 3299 309.
10. Christensen HR, Frokiaer H, Pestka JJ. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 2002 168 : 171 8.
11. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002 20 : 197 216.
12. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003 21 : 335 76.
13. Kopp E, Medzhitov R. Recognition of microbial infection by Toll-like receptors. Curr Opin Immunol 2003 15 : 396 401.
14. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001 2 : 675 80.
15. Barton GM, Medzhitov R. Control of adaptive immune responses by Toll-like receptors. Curr Opin Immunol 2002 14 : 380 3.
16. Hornef MW, Frisan T, Vandewalle A et al. Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J Exp Med 2002 195 : 559 70.
17. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR-4 in inflammatory bowel disease. Infect Immun 2000 68 : 7010 17.
18. Ortega-Cava CF, Ishihara S, Rumi MA et al. Strategic compartmentalization of Toll-like receptor 4 in the mouse gut. J Immunol 2003 170 : 3977 85.
19. Dieleman LA, Palmen MJ, Akol H et al. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 1998 114 : 385 91.
20. Jung HC, Eckmann L, Yang SK et al. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 1995 95 : 55 65.
21. Herfarth H, Brand K, Rath HC et al. Nuclear factor-kappa B activity and intestinal inflammation in dextran sulphate sodium (DSS)-induced colitis in mice is suppressed by gliotoxin. Clin Exp Immunol 2000 120 : 59 65.
22. Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Annu Rev Immunol 2002 20 : 495 549.
23. Rachmilewitz D, Katakura K, Karmeli F et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004 126 : 520 8.
24. Sansonetti PJ. War and peace at mucosal surfaces. Nat Rev Immunol 2004 4 : 953 64.
25. Kelly D, Campbell JI, King TP et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 2004 5 : 104 12.
26. Lange S, Delbro DS, Jennische E et al. The role of the Lps gene in experimental ulcerative colitis in mice. APMIS 1996 104 : 823 33.
27. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004 118 : 229 41.
28. Araki A, Kanai T, Ishikura T et al. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis. J Gastroenterol 2005 40 : 16 23.
29. Dubuquoy L, Jansson EA, Deeb S et al. Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology 2003 124 : 1265 76.